.Merck defeats incomes assumptions, brings up purchases outlook on sturdy need for leading medications like Keytruda CNBCMerck & Co. (MRK US) Beats Income Projections as Keytruda Sales Rise BloombergMerck Supply: Pharma Giant Posts Solid End Results, But Expectation Falls Short Investor's Service DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats profit as well as sales requirements surrounded by Keytruda asset, however supplies mixed full-year expectation MarketWatch.